跳轉至內容
Merck
  • Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: development and characterization.

Precursor system of liquid crystalline phase containing propolis microparticles for the treatment of periodontal disease: development and characterization.

Drug development and industrial pharmacy (2008-03-26)
Marcos Luciano Bruschi, Osvaldo de Freitas, Elza Helena Guimarã Es Lara, Heitor Panzeri, Maria Palmira Daflon Gremião, David Simon Jones
摘要

Precursor systems of liquid crystalline phase were prepared using the surfactant PPG-5-Ceteth-20, isopropyl myristate, and water; gelatin microparticles containing propolis were then added into these systems. Homogeneity of dispersion, the in-system microparticle morphology, and sedimentation behavior of each formulation were evaluated. The rheological and mechanical properties (hardness, compressibility, and adhesiveness), the work of syringing, and the propolis release profile were also evaluated. All the formulations exhibited pseudoplastic flow and thixotropy, and they displayed storage modulus, loss modulus, dynamic viscosity, and loss tangent that depended on temperature, frequency, and composition. Mechanical properties varied significantly among the formulations being affected by changes in the composition and temperature. Raising the concentration of surfactant and adding propolis microparticles significantly decreased the work of syringing. The drug release was non-Fickian (anomalous) and there was no significant difference between the tested systems in the times required for 10%, 30%, and 50% release of the initial drug loading.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
1-十六烷醇, ReagentPlus®, 99%
Sigma-Aldrich
1-十六烷醇, ≥99%
Sigma-Aldrich
1-十六烷醇, 95%
Supelco
1-十六烷醇, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
鲸蜡醇, analytical standard
鲸蜡醇, European Pharmacopoeia (EP) Reference Standard